Skye Bioscience, Inc.
SKYE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18,441 | $23,838 | $46,421 | $68,416 |
| Short-Term Investments | $16,871 | $24,747 | $12,803 | $0 |
| Receivables | $0 | $13 | $6 | $5 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4,612 | $1,984 | $160 | $207 |
| Total Curr. Assets | $39,925 | $50,583 | $63,028 | $70,827 |
| Property Plant & Equip (Net) | $1,346 | $1,524 | $1,712 | $1,883 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $54 | $54 | $54 | $54 |
| Total NC Assets | $1,399 | $1,578 | $1,765 | $1,937 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $41,324 | $52,161 | $64,793 | $72,764 |
| Liabilities | – | – | – | – |
| Payables | $2,825 | $3,223 | $1,714 | $569 |
| Short-Term Debt | $202 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5,341 | $4,026 | $797 | $549 |
| Total Curr. Liab. | $8,368 | $8,312 | $5,319 | $4,339 |
| LT Debt | $120 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $120 | $172 | $223 | $273 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $322 | $368 | $412 | $456 |
| Total Liabilities | $8,488 | $8,484 | $5,543 | $4,612 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $31 | $31 | $31 | $31 |
| Retained Earnings | -$172,433 | -$159,678 | -$142,053 | -$130,950 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $205,238 | $0 | $0 | $0 |
| Total Equity | $32,836 | $43,677 | $59,250 | $68,152 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $41,324 | $52,161 | $64,793 | $72,764 |
| Net Debt | -$18,119 | -$23,838 | -$46,421 | -$68,416 |